US-based clinical trial software company Medidata has partnered with contract research organisation Aixial Group to streamline clinical trial execution and attain database lock more quickly.
Aixial will migrate clinical data from one of its business units onto the Medidata Platform to create a Single Source of Truth, which aims to support patient data privacy and enable better-informed clinical trial decisions while tracking patient data throughout the study.
Go deeper with GlobalData
Medidata said its offering will also help Aixial Group enhance clinical trial experiences for both patients and sponsors.
Aixial Group chief technology officer Tim Corbett-Clark said: “Consolidating clinical data onto the Medidata Platform will power the experience and expertise of our teams to deliver this superior service for our customers.”
Medidata global sales head and executive vice-president Janet Butler said: “This engagement enables Aixial Group to provide increased consistency and control within their operations, helping them further excel in the global clinical research market.
“Medidata Rave EDC will enhance their support for studies of any size, length, or complexity and translate their productivity into more patients accessing better treatments sooner.”
How well do you really know your competitors?
Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.
Thank you!
Your download email will arrive shortly
Not ready to buy yet? Download a free sample
We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form
By GlobalDataMedidata’s solutions have been used in more than 34,000 clinical trials to date, with more than one million registered users across around 2,200 customers.
The company is a subsidiary of French software provider Dassault Systèmes.
Earlier this year, Eisai began using Medidata’s Clinical Data Studio to ‘transform and modernise’ the trial efficiency and patient experience.
The AI-driven platform is part of the Medidata platform, which centrally manages data from several sources to improve data reliability across the clinical trial ecosystem.
In November last year, Medidata launched two data integration offerings, Clinical Data Studio and Health Record Connect, designed to expedite clinical trials.
The solutions are based on an open, interconnected and scalable data design that is intended to strengthen and optimise clinical data workflows.
